KIB OpenIR
Tripterygium wilfordii protects against an animal model of autoimmune hepatitis
Zhang,Ting; Rao,Qianru; Dai,Manyun; Zhao,Qi; Li,Fei
2023
Source PublicationJOURNAL OF ETHNOPHARMACOLOGY
ISSN1872-7573
Volume309Pages:116365
AbstractEthnopharmacological relevance: Tripterygium wilfordii tablets (TWT) is widely used to treat autoimmune diseases such as rheumatoid arthritis. Celastrol, one main active ingredient in TWT, has been shown to produce a variety of beneficial effects, including anti-inflammatory, anti-obesity, anti-cancer, and immunomodulatory. However, whether TWT could protect against Concanavalin A (Con A)-induced hepatitis remains unclear.The aim of the study: This study aims to investigate the protective effect of TWT against Con A-induced hepatitis and elucidate the underlying mechanism.Materials and methods: Metabolomic analysis, pathological analysis, biochemical analysis, qPCR and Western blot analysis and the Pxr-null mice were used in this study.Results: The results indicated that TWT and its active ingredient celastrol could protect against Con A-induced acute hepatitis. Plasma metabolomics analysis revealed that metabolic perturbations related to bile acid and fatty acid metabolism induced by Con A were reversed by celastrol. The level of itaconate in the liver was increased by celastrol and speculated as an active endogenous compound mediating the protective effect of celastrol. Administration of 4-octanyl itaconate (4-OI) as a cell-permeable itaconate mimicker was found to attenuate Con A-induced liver injury through activation of the pregnane X receptor (PXR) and enhancement of the transcription factor EB (TFEB)-mediated autophagy.Conclusions: Celastrol increased itaconate and 4-OI promoted activation of TFEB-mediated lysosomal autophagy to protect against Con A-induced liver injury in a PXR-dependent manner. Our study reported a protective effect of celastrol against Con A-induced AIH via an increased production of itaconate and upregulation of TFEB. The results highlighted that PXR and TFEB-mediated lysosomal autophagic pathway may offer promising therapeutic target for the treatment of autoimmune hepatitis.
KeywordTripterygium wilfordii tablets Celastrol Concanavalin A Autophagy TFEB PXR PREGNANE-X-RECEPTOR CHOLESTATIC LIVER-INJURY CELASTROL PROTECTS AUTOPHAGY OBESITY DYSFUNCTION DOMAIN
Subject AreaPlant Sciences ; Pharmacology & Pharmacy ; Integrative & Complementary Medicine
DOI10.1016/j.jep.2023.116365
Indexed BySCI
WOS IDWOS:000956588000001
Citation statistics
Cited Times:5[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.kib.ac.cn/handle/151853/75501
Collection中国科学院昆明植物研究所
Recommended Citation
GB/T 7714
Zhang,Ting,Rao,Qianru,Dai,Manyun,et al. Tripterygium wilfordii protects against an animal model of autoimmune hepatitis[J]. JOURNAL OF ETHNOPHARMACOLOGY,2023,309:116365.
APA Zhang,Ting,Rao,Qianru,Dai,Manyun,Zhao,Qi,&Li,Fei.(2023).Tripterygium wilfordii protects against an animal model of autoimmune hepatitis.JOURNAL OF ETHNOPHARMACOLOGY,309,116365.
MLA Zhang,Ting,et al."Tripterygium wilfordii protects against an animal model of autoimmune hepatitis".JOURNAL OF ETHNOPHARMACOLOGY 309(2023):116365.
Files in This Item: Download All
File Name/Size DocType Version Access License
1-s2.0-S037887412300(13950KB)期刊论文出版稿开放获取CC BY-NC-SAView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhang,Ting]'s Articles
[Rao,Qianru]'s Articles
[Dai,Manyun]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhang,Ting]'s Articles
[Rao,Qianru]'s Articles
[Dai,Manyun]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhang,Ting]'s Articles
[Rao,Qianru]'s Articles
[Dai,Manyun]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: 1-s2.0-S0378874123002337-main.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.